In the U.S., healthcare spending is second only to defense. Why? Because people will always get sick, and in response, innovators will always seek to create technologies and processes to help them get better.
For investors, this means that healthcare is a stable industry in which to invest. It consistently outperforms the market, and often, healthcare investments trade at 10-15 times EBITDA multiple.
However, some investors shy away from this market because the field feels foreign. An emerging healthcare collaborative is crucial for New Orleans to connect investors and innovators to bring new advances to the healthcare industry.